THIADIAZOLIDINEDIONES AS GSK 3 INHIBITORS
The present invention relates to new thiadiazolidmediones of formula (I) or any pharmaceutically acceptable salt solvate or prodrug thereof and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved particularly neurodegenerative diseases inflammatory and autoi...
Saved in:
Main Authors | , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
24.04.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to new thiadiazolidmediones of formula (I) or any pharmaceutically acceptable salt solvate or prodrug thereof and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved particularly neurodegenerative diseases inflammatory and autoimmune diseases and cardiovascular disorders. Additionally there is provided a process for preparing such compounds as well as pharmaceutical compositions comprising them. |
---|---|
Bibliography: | Application Number: IN2014DELNP7885 |